Fig. 3.
Fig. 3. Expansion and differentiation into DCs of SP (CD7−45RA+), DP (CD7+45RA+), and bulk CD34+ HPCs cultured under the standard condition. / (A) Viable cell numbers were normalized relative to 1 × 105 seeded HPCs; means ± SD (n = 5 to 8); differences were significant on days 5, 8, and 12 (P =  .03 to .007) between DP and SP HPCs, and on day 8 (P =  .001) and 12 (P =  .0005) between DP and bulk HPCs. (B) FACS analysis of day 8 CD1a-FITC-labeled cells; means ± SD CD1a+ DC percentages (n = 8); differences between DP and SP or bulk HPCs (P ≤ .001), between SP and bulk HPCs (P = .07).

Expansion and differentiation into DCs of SP (CD745RA+), DP (CD7+45RA+), and bulk CD34+ HPCs cultured under the standard condition.

(A) Viable cell numbers were normalized relative to 1 × 105 seeded HPCs; means ± SD (n = 5 to 8); differences were significant on days 5, 8, and 12 (P =  .03 to .007) between DP and SP HPCs, and on day 8 (P =  .001) and 12 (P =  .0005) between DP and bulk HPCs. (B) FACS analysis of day 8 CD1a-FITC-labeled cells; means ± SD CD1a+ DC percentages (n = 8); differences between DP and SP or bulk HPCs (P ≤ .001), between SP and bulk HPCs (P = .07).

Close Modal

or Create an Account

Close Modal
Close Modal